Edwards Lifesciences EW
NYSE EW
$85.91 -0.81 (-0.93%)
As of: Sep 9, 2026 · 3:27 PM EDT

Edwards Lifesciences (EW) EBITDA Margin (QoQ) (2009 - 2026)

Analysis

Edwards Lifesciences (EW) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.43 Bn 177.83 Bn 7.27 Bn
2 Intuitive Surgical 124.55 Bn 119.33 Bn 1.96 Bn
3 Medtronic 117.91 Bn 109.10 Bn 6.34 Bn
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn
5 Boston Scientific 66.23 Bn 65.69 Bn 3.85 Bn
6 Edwards Lifesciences 49.46 Bn 45.21 Bn 1.35 Bn
7 Alcon 33.87 Bn 32.41 Bn 1.68 Bn
8 Dexcom 32.08 Bn 30.13 Bn 830.00 Mn
9 Steris 21.05 Bn 20.56 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.00
Mar 31, 2026 1,934.00
Dec 31, 2025 -1,015.00
Sep 30, 2025 -706.00
Jun 30, 2025 -111.00
Mar 31, 2025 539.00
Dec 31, 2024 -333.00
Sep 30, 2024 -88.00
Jun 30, 2024 52.00
Mar 31, 2024 -114.00
Dec 31, 2023 -204.00
Sep 30, 2023 882.00
Jun 30, 2023 -1,120.00
Mar 31, 2023 -1,419.00
Dec 31, 2022 1,548.00
Sep 30, 2022 -294.00
Jun 30, 2022 73.00
Mar 31, 2022 456.00
Dec 31, 2021 -163.00
Sep 30, 2021 -961.00